![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1619058 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of GOLGA2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1619058 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GOLGA2 mRNA | CTD | PMID:22206623 | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | RGD:1347402 | 6480464 | Dinitrochlorobenzene binds to GOLGA2 protein | CTD | PMID:32991956 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1619058 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GOLGA2 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of GOLGA2 mRNA | CTD | PMID:26496021 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:1347402 | 6480464 | Dihydrotestosterone results in increased expression of GOLGA2 mRNA | CTD | PMID:29581250 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GOLGA2 protein | CTD | PMID:12361703 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1619058 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GOLGA2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1619058 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GOLGA2 mRNA | CTD | PMID:17942748 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of GOLGA2 mRNA | CTD | PMID:21346803 | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of GOLGA2 protein | CTD | PMID:34915118 | aflatoxin B1 | increases expression | ISO | RGD:1619058 | 6480464 | Aflatoxin B1 results in increased expression of GOLGA2 mRNA | CTD | PMID:19770486 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GOLGA2 mRNA | CTD | PMID:16483693 | arsenous acid | increases expression | ISO | RGD:1347402 | 6480464 | Arsenic Trioxide results in increased expression of GOLGA2 mRNA | CTD | PMID:20458559 | benzo[a]pyrene | increases expression | ISO | RGD:1619058 | 6480464 | Benzo(a)pyrene results in increased expression of GOLGA2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:1347402 | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of GOLGA2 mRNA | CTD | PMID:26496021 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GOLGA2 mRNA | CTD | PMID:33296240, PMID:34947998 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of GOLGA2 gene | CTD | PMID:28505145 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GOLGA2 mRNA | CTD | PMID:25181051 | cadmium dichloride | increases expression | ISO | RGD:1619058 | 6480464 | Cadmium Chloride results in increased expression of GOLGA2 mRNA | CTD | PMID:20883709 | caffeine | decreases phosphorylation | ISO | RGD:1347402 | 6480464 | Caffeine results in decreased phosphorylation of GOLGA2 protein | CTD | PMID:35688186 | carmustine | decreases expression | ISO | RGD:1347402 | 6480464 | Carmustine results in decreased expression of GOLGA2 mRNA | CTD | PMID:15980968 | chloroquine | affects localization | ISO | RGD:1347402 | 6480464 | Chloroquine affects the localization of GOLGA2 protein | CTD | PMID:29940786 | coumestrol | decreases expression | ISO | RGD:1347402 | 6480464 | Coumestrol results in decreased expression of GOLGA2 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | ISO | RGD:1347402 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | RGD:1347402 | 6480464 | Cyclosporine results in increased expression of GOLGA2 mRNA | CTD | PMID:20106945, PMID:25562108 | dexamethasone | increases expression | ISO | RGD:1619058 | 6480464 | Dexamethasone results in increased expression of GOLGA2 mRNA | CTD | PMID:22733784 | diarsenic trioxide | increases expression | ISO | RGD:1347402 | 6480464 | Arsenic Trioxide results in increased expression of GOLGA2 mRNA | CTD | PMID:20458559 | Enterolactone | multiple interactions | ISO | RGD:1347402 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA | CTD | PMID:19167446 | enzyme inhibitor | multiple interactions | ISO | RGD:1347402 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GOLGA2 protein | CTD | PMID:23301498 | ethanol | affects splicing | ISO | RGD:1619058 | 6480464 | Ethanol affects the splicing of GOLGA2 mRNA | CTD | PMID:30319688 | fenthion | decreases expression | ISO | RGD:1619058 | 6480464 | Fenthion results in decreased expression of GOLGA2 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | RGD:1619058 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GOLGA2 mRNA | CTD | PMID:22206623 | folic acid | decreases expression | ISO | RGD:1347402 | 6480464 | Folic Acid results in decreased expression of GOLGA2 mRNA | CTD | PMID:21867686 | ivermectin | decreases expression | ISO | RGD:1347402 | 6480464 | Ivermectin results in decreased expression of GOLGA2 protein | CTD | PMID:32959892 | methidathion | affects expression | ISO | RGD:1619058 | 6480464 | methidathion affects the expression of GOLGA2 mRNA | CTD | PMID:34813904 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GOLGA2 mRNA | CTD | PMID:20360939 | paracetamol | affects expression | ISO | RGD:1619058 | 6480464 | Acetaminophen affects the expression of GOLGA2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GOLGA2 mRNA | CTD | PMID:33387578 | phenethyl caffeate | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GOLGA2 mRNA | CTD | PMID:20360939 | pirinixic acid | multiple interactions | ISO | RGD:1619058 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GOLGA2 mRNA | CTD | PMID:19710929 | sodium arsenite | increases expression | ISO | RGD:1619058 | 6480464 | sodium arsenite results in increased expression of GOLGA2 mRNA | CTD | PMID:20883709 | testosterone enanthate | affects expression | ISO | RGD:1347402 | 6480464 | testosterone enanthate affects the expression of GOLGA2 mRNA | CTD | PMID:17440010 | thapsigargin | increases expression | ISO | RGD:1347402 | 6480464 | Thapsigargin results in increased expression of GOLGA2 mRNA | CTD | PMID:22378314 | titanium dioxide | increases expression | ISO | RGD:1619058 | 6480464 | titanium dioxide results in increased expression of GOLGA2 mRNA | CTD | PMID:23131501 | torcetrapib | increases expression | ISO | RGD:1347402 | 6480464 | torcetrapib results in increased expression of GOLGA2 mRNA | CTD | PMID:23228038 | triptonide | increases expression | ISO | RGD:1619058 | 6480464 | triptonide results in increased expression of GOLGA2 mRNA | CTD | PMID:33045310 | trovafloxacin | multiple interactions | ISO | RGD:1619058 | 6480464 | [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GOLGA2 mRNA | CTD | PMID:18930950 | tungsten | decreases expression | ISO | RGD:1619058 | 6480464 | Tungsten results in decreased expression of GOLGA2 mRNA | CTD | PMID:30912803 | tunicamycin | increases expression | ISO | RGD:1347402 | 6480464 | Tunicamycin results in increased expression of GOLGA2 mRNA | CTD | PMID:22378314 | valproic acid | increases expression | ISO | RGD:1347402 | 6480464 | Valproic Acid results in increased expression of GOLGA2 mRNA | CTD | PMID:19101580, PMID:23179753 | valproic acid | increases methylation | ISO | RGD:1347402 | 6480464 | Valproic Acid results in increased methylation of GOLGA2 gene | CTD | PMID:29154799 | |